COVID-19 pandemic
South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.
Sources: The Korea Herald
Changes
- South Korea signs a agreement with Pfizer to purchase 30 million doses of the Pfizer-BioNTech COVID-19 vaccine in 2022 as part of plan to administering 50 million "booster" dose.
- South Korea signs an agreement with Pfizer to purchase 30 million doses of the Pfizer–BioNTech COVID-19 vaccine in 2022 as part of a plan to administer 50 million "booster" doses of the vaccine.